At the request of Reps. Mike Coffman, R-CO., and Ann McLane Kuster, D-N.H., the Government Accountability Office (“the GAO”) agreed Sept. 27 that it “will review the way the Department of Veterans Affairs (“the VA”) treats patients who suffer from post-traumatic stress disorder (PTSD) and other combat-related conditions.” In particular, the GAO will focus on “how heavily the VA relies on powerful psychotropic drugs to treat patients.”
As reported ...
Continue Reading →